Good Works II Acquisition (GWIIW) Financial Report Summaries

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

External links

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	Coll. sophomore Bad

New words: acute, advance, advanced, announced, BCA, bone, candidate, clinical, commercializing, contemplated, customary, DB, decrease, demonstrate, detail, develop, disease, DRE, Drug, efficacy, endpoint, ExoFlo, expedite, Extension, extracellular, FDA, Food, governmental, half, hereinafter, hospitalized, lead, letter, License, LOI, medical, medicine, mesenchymal, minimum, mortality, parent, Phase, platform, power, product, promising, proportional, proprietary, receipt, reclassified, regenerative, respiratory, Rollover, satisfaction, statutory, stem, subsidiary, surviving, syndrome, technology, therapeutic, therapy, Topco, treating, trial, unmet, vesicle, Wyoming

Removed: acquire, breach, commitment, conducting, exclusivity, favorable, intention, paying, satisfy, shopping

From filing 10-Q 2022 Q3

Financial report summary

Management Discussion

As of September 30, 2022, we have not commenced any operations. All activity for the period from July 27, 2020 (inception) through September 30, 2022, relates to our formation and initial public offering (“Public Offering” of “IPO”) that occurred on July 14, 2021, and, since the completion of the IPO, searching for a target to consummate a Business Combination. We will not generate any operating revenues until after the completion of a Business Combination, at the earliest. We will generate non-operating income in the form of interest income from the proceeds derived from the Public Offering and placed in the Trust Account (defined below). There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements, December 31, 2021.